Sound Pharmaceuticals Stock

soundpharmaceuticals.comBioTechFounded: 2018Funding to Date: $25.95MM

Sound Pharmaceuticals is a bio-pharmaceutical platform developing novel treatments to prevent and treat hearing loss and tinnitus. The company uses molecular biology, immunohistochemistry and electrophysiology that have lead to the development of preclinical models of hearing loss and tinnitus that are translating into successful clinical trials.

Enterprise Value (based on primary financings)

Register for Details

For more details on financing and valuation for Sound Pharmaceuticals, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Sound Pharmaceuticals investors also invested in these private companies

KEC Ventures
Cystic Fibrosis Foundation

Team

Management Team

Jonathan Kil
Chief Executive Officer & Chief Medical Officer
John Sullivan
Chief Financial Officer

Other companies like Sound Pharmaceuticals in the BioTech sector

Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.89B
Sector
Last Round Est. Valuation
$872.62MM
Sector
Last Round Est. Valuation
$486.63MM
Sector
Last Round Est. Valuation
$197.73MM
Sector
Last Round Est. Valuation
$50.4MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$185MM